glp-1 medication side effects management strategies Managing Adverse Effects: Clinician Managing the costs of GLP-1

I don't snack at night anymore and my pants actually button comfortably again

Bak YK, Lampe JW, Sung MK

Public Health Nutr 18(8):14821487

Orlistat, phentermine/topiramate, naltrexone/bupropion, and the incretin-based drugs liraglutide and semaglutide, both GLP-1 receptor agonists (GLP-1RA), and tirzepatide, a biased dual GIP/GLP-1 receptor agonist, are currently both FDA and EMA approved for the management of non-syndromic obesity 10

A proof-of-concept study in non-human primates assessed the safety and prophylactic anti-fecundity potential of non-adjuvanted DNA immunization followed by a subcutaneous challenge with 1,000 Sm cercariae